Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Exscientia Reports Formation Of Joint Venture With University Of Oxford Target Discovery Institute, Named Xcellomics, ‘designed to source cellular functional assays from the global academic community to develop novel screens…’

By Benzinga Newsdesk
March 10, 9:22 AM
Program open at no-cost to any academic researcher interested in submitting a proposal OXFORD, England--(BUSINESS WIRE)-- Exscientia (NASDAQ:EXAI) and the University of Oxford Target Discovery Institute (Oxford TDI)

EXAI

Read More
2 minute read

Exscientia and Sanofi Announced Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-engineered Medicines Exscientia to Receive Upfront Cash Payment of $100M From Sanofi Plus Up to $5.2B in Milestone, Regulatory Payments

By Charles Gross
January 7, 6:53 AM
Sanofi and Exscientia announced today a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia's end-to-end AI-driven platform utilizing actual patient samples.

EXAI